NeuroSigma taps CCG for IR

LOS ANGELES: NeuroSigma, a medical technology company, has appointed CCG Investor Relations to implement a strategic communications and investor relations campaign.

LOS ANGELES: NeuroSigma, a medical technology company, has appointed CCG Investor Relations to implement a strategic communications and investor relations campaign.

NeuroSigma develops therapies in clinical trials that target epilepsy, depression, post-traumatic stress disorders, and obesity.

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register
Already registered?
Sign in